High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update
Articolo
Data di Pubblicazione:
1993
Citazione:
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update / A. M. Gianni, S. Siena, M. Bregni, F. Lombardi, L. Gandola, M. Di Nicola, M. Magni, F. Peccatori, P. Valagussa, G. Bonadonna. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 4:10(1993 Dec), pp. 889-91-891.
Abstract:
Very few studies using high-dose therapy and autologous bone marrow transplantation have a long (i.e., > 3 years) follow-up. We report here the 6-year update of a study employing high-dose sequential chemo-radiotherapy in 25 patients with poor-risk Hodgkin's disease.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Prednisone; Combined Modality Therapy; Humans; Salvage Therapy; Vincristine; Vinblastine; Cyclophosphamide; Bleomycin; Epirubicin; Doxorubicin; Whole-Body Irradiation; Survival Rate; Cisplatin; Mechlorethamine; Adult; Treatment Outcome; Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Procarbazine; Actuarial Analysis; Hodgkin Disease; Bone Marrow Transplantation; Female
Elenco autori:
A. M. Gianni, S. Siena, M. Bregni, F. Lombardi, L. Gandola, M. Di Nicola, M. Magni, F. Peccatori, P. Valagussa, G. Bonadonna
Link alla scheda completa: